Company

NTrans Technologies BV

Biotechnology Research Nl 7 employees

Employees: 7
Contacts: 2
Emails: 2
Phones: 1

ntranstechnologies.com LinkedIn Crunchbase

NTrans Technologies BV Overview

Headquarters: Nl
Phone Number: Available in AeroLeads
Website: ntranstechnologies.com
Industry: Biotechnology Research
Employees: 7
Founded: 2015
Funding: 1.6M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Stem cell technology transduction CRISPR/Cas gene editing

About NTrans Technologies BV

Imagine a world where we conquer cancer and genetic diseases. At NTrans Technologies, we solve key challenges in cell and gene therapy: Delivering life-changing therapies to the right cells and tissues. We leverage nature’s own mechanisms for cellular uptake to ensure efficient and safe therapeutic delivery. Welcome to the next frontier of medicine. Our proprietary platform is GMP-ready and sets a new standard in cell and gene therapy. We use a non-viral delivery system to harness macropinocytosis - a natural cellular uptake process - for precise and secure delivery of gene-editing technologies. The mission of NTrans Technologies is to become the leading non-viral delivery platform in cell and gene therapy. Please contact us at: info@ntranstechnologies.com

NTrans Technologies BV Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

NTrans Technologies BV Org Chart

Sample employees and titles

Name	Title	Location	Contact
Marco De Boer (Ph.d., Mba)	CEO and Co-founder of Predica	Amsterdam, North Holland, Netherlands	Email Phone
Ester Weijers	CEO Ntrans Technologies - Innovation	Almere, Flevoland, Netherlands	Email
Camilo F Muñoz Segovia	Senior Scientist at Ntrans Technologies		View
Yali Gal-On	Research Technician	Netherlands	View